Agios Pharmaceuticals (AGIO) Shares Outstanding (2012 - 2026)

Agios Pharmaceuticals has reported Shares Outstanding for 15 years, with the latest figure at $75.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding fell 99.9% year-over-year to $75.6 million; the trailing twelve-month figure through Mar 2026 stood at $75.6 million (down 99.9% YoY), and the FY2025 full-year result was $58.4 million, down 99.92% from the prior year.
• Shares Outstanding for Q1 2026 stood at $75.6 million, up from $58.4 million in the prior quarter.
• The five-year high for Shares Outstanding was $74.3 billion in Q2 2025, with the low at $58.3 million in Q3 2025.
• Historically, Shares Outstanding has averaged $47.0 billion across 5 years, with a median of $71.8 billion in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding surged 101591.78% — and 2025, when it slumped 99.92%.
• Agios Pharmaceuticals' Shares Outstanding stood at $71.3 million in 2022, then climbed by 1.27% to $72.2 million in 2023, then jumped by 101578.47% to $73.4 billion in 2024, then slumped by 99.92% to $58.4 million in 2025, then gained by 29.27% to $75.6 million in 2026.
• The last three Shares Outstanding figures came in at $75.6 million (Q1 2026), $58.4 million (Q4 2025), and $58.3 million (Q3 2025), per Business Quant data.